Literature DB >> 12371994

Body size, dialysis dose and death risk relationships among hemodialysis patients.

Edmund G Lowrie1, Zhensheng Li, Norma Ofsthun, J Michael Lazarus.   

Abstract

BACKGROUND: The normalized treatment ratio, Kt/V derived from urea kinetic models (UKM), is a commonly used measure of dialysis dose. This measure assumes that smaller patients with low volume of urea distribution (V) require proportionately less total treatment (Kt) than larger patients. The conclusion has been questioned because the UKM use assumptions that could make them invalid for accurately predicting a clinical outcome like survival. It is possible that a relationship exists between Kt and body size whereby a different Kt is required for different sizes. This study therefore explored the relationships among body size, Kt, and death risk focusing on possible interactions between Kt and size.
METHODS: The sample included 43,334 patients treated on January 1, 1999. Survival time was modeled using Kt or body size groups to evaluate the shape of the risk profiles. Kt and the size measures were then evaluated together as continuous functions both in main effects (that is, Kt and size) and interaction models to see if the association of Kt with risk might be different for different sizes. The size measures were body weight, weight adjusted statistically for height, body surface area (BSA), weight divided by height (wt/ht) and the body mass index (BMI).
RESULTS: The log of risk decreased in rough linear fashion for Kt, weight, weight for height, and BSA. The log-risk relationships were "reverse J-shaped" for wt/ht and BMI. The main effects models suggested improved survival with increasing Kt and all of the size measures. Adding an interaction term increased the benefit associated with increasing Kt and for weight, weight for height and BSA at low values of Kt and size. A significant, positive interaction term mitigated those effects at higher values. Thus, the death risk penalties associated with reducing Kt among small patients were as great as or greater than they were among large patients. A similar pattern was observed for V. Adding the interaction to the BMI model destroyed the main effects, so that there was no significant association between risk and either Kt or BMI. A cross-categorical model of BMI and Kt, however, revealed improving survival with increasing Kt among both low and high BMI patients throughout the range of Kt.
CONCLUSIONS: Evidence supporting the intuition that smaller patients require proportionately lower dialysis dose than larger patients was not found. To the contrary, smaller patients suffer as much risk as or more risk than larger patients from reducing Kt. Deciding dialysis treatment using a Kt/V based intuition may lead to avoidable under-dialysis particularly among small patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371994     DOI: 10.1046/j.1523-1755.2002.00642.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients.

Authors:  Heba Wahid El Said; Osama Mahmoud Mohamed; Tamer Wahid El Said; Ahmed Bahaa El Serwi
Journal:  Int Urol Nephrol       Date:  2017-03-17       Impact factor: 2.370

Review 2.  Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench.

Authors:  Neda Naderi; Carola-Ellen Kleine; Christina Park; Jui-Ting Hsiung; Melissa Soohoo; Ekamol Tantisattamo; Elani Streja; Kamyar Kalantar-Zadeh; Hamid Moradi
Journal:  Prog Cardiovasc Dis       Date:  2018-07-04       Impact factor: 8.194

3.  Obesity and mortality risk among younger dialysis patients.

Authors:  Ellen K Hoogeveen; Nynke Halbesma; Kenneth J Rothman; Theo Stijnen; Sandra van Dijk; Friedo W Dekker; Elisabeth W Boeschoten; Renée de Mutsert
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

4.  Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients.

Authors:  Nazanin Noori; Joel D Kopple; Csaba P Kovesdy; Usama Feroze; John J Sim; Sameer B Murali; Amanda Luna; Myra Gomez; Claudia Luna; Rachelle Bross; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 8.237

Review 5.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

Review 6.  Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.

Authors:  John T Daugirdas; Nathan W Levin; Peter Kotanko; Thomas A Depner; Martin K Kuhlmann; Glenn M Chertow; Michael V Rocco
Journal:  Semin Dial       Date:  2008 Sep-Oct       Impact factor: 3.455

7.  Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.

Authors:  John T Daugirdas; Thomas A Depner; Tom Greene; Martin K Kuhlmann; Nathan W Levin; Glenn M Chertow; Michael V Rocco
Journal:  Semin Dial       Date:  2008 Sep-Oct       Impact factor: 3.455

8.  Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes.

Authors:  Jula K Inrig; Uptal D Patel; Robert D Toto; Donal N Reddan; Jonathan Himmelfarb; Robert M Lindsay; John Stivelman; James F Winchester; Lynda A Szczech
Journal:  Kidney Int       Date:  2009-09-02       Impact factor: 10.612

9.  Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature.

Authors:  T Pliakogiannis; L Trpeski; H Taskapan; H Shah; M Ahmad; S Fenton; J Bargman; D Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006-12-14       Impact factor: 2.266

10.  Relationship between the target dose for hemodialysis adequacy and nutritional assessment.

Authors:  Tezcan Kaya; Savas Sipahi; Hakan Cinemre; Cengiz Karacaer; Ceyhun Varim; Ahmet Nalbant; Ali Tamer
Journal:  Ann Saudi Med       Date:  2016-04-03       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.